These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11874221)

  • 21. Clinical development of citalopram.
    Willetts J; Lippa A; Beer B
    J Clin Psychopharmacol; 1999 Oct; 19(5 Suppl 1):36S-46S. PubMed ID: 10507507
    [No Abstract]   [Full Text] [Related]  

  • 22. [Escitalopram for intervention of psychiatric adverse events during peginterferon-alfa-2a and ribavirin treatment for chronic hepatitis C].
    Qi M; Zhou B; Su M; Pan J; Zhang H
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jul; 33(7):1012-6. PubMed ID: 23895843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferon-induced depression and cognitive impairment in hepatitis C virus patients: a 72 week prospective study.
    Reichenberg A; Gorman JM; Dieterich DT
    AIDS; 2005 Oct; 19 Suppl 3():S174-8. PubMed ID: 16251815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Use of anxiolytics and antidepressants before and after treatment with interferon-alpha and ribavirin in patients with hepatitis C].
    García-Toro M; Vilella Martorell A; Carral Martínez M; Jimeno Beltrán T; Román Ruiz del Moral Y; Pradas Guerrero C; Gili Planas M; Roca Bennasar M
    Gastroenterol Hepatol; 2011 Apr; 34(4):307-8. PubMed ID: 21376422
    [No Abstract]   [Full Text] [Related]  

  • 25. The precipitation of mania by citalopram in a patient with interferon-induced depression.
    Beckwith AR
    Psychosomatics; 2008; 49(4):362-3. PubMed ID: 18621943
    [No Abstract]   [Full Text] [Related]  

  • 26. Plasma levels of citalopram in depressed patients with hepatitis C.
    Gleason OC; Yates WR; Philipsen MA; Isbell MD; Pollock BG
    Psychosomatics; 2004; 45(1):29-33. PubMed ID: 14709758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of association of indoleamine 2,3-dioxygenase polymorphisms with interferon-alpha-related depression in hepatitis C.
    Galvão-de Almeida A; Quarantini LC; Sampaio AS; Lyra AC; Parise CL; Paraná R; de Oliveira IR; Koenen KC; Miranda-Scippa A; Guindalini C
    Brain Behav Immun; 2011 Oct; 25(7):1491-7. PubMed ID: 21693183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Introduction. Overview of citalopram.
    Lippa AS; Beer B; Cancro R
    J Clin Psychopharmacol; 1999 Oct; 19(5 Suppl 1):1S-3S. PubMed ID: 10507504
    [No Abstract]   [Full Text] [Related]  

  • 29. Citalopram approved for treatment of depression.
    Am J Health Syst Pharm; 1998 Oct; 55(19):1963. PubMed ID: 9784778
    [No Abstract]   [Full Text] [Related]  

  • 30. Changes in depressive symptoms and impact on treatment course among hepatitis C patients undergoing interferon-α and ribavirin therapy: a prospective evaluation.
    Chapman J; Oser M; Hockemeyer J; Weitlauf J; Jones S; Cheung R
    Am J Gastroenterol; 2011 Dec; 106(12):2123-32. PubMed ID: 21826113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ribavirin may be an important factor in IFN-induced neuropsychiatric effects.
    Asnis GM; De La Garza R; Miller AH; Raison CL
    J Clin Psychiatry; 2004 Apr; 65(4):581; author reply 581-2. PubMed ID: 15119925
    [No Abstract]   [Full Text] [Related]  

  • 32. Depressive symptoms in patients with hepatitis C treated with pegylated interferon alpha therapy: a 24-week prospective study.
    Pavlović Z; Delić D; Marić NP; Vuković O; Jašović-Gašić M
    Psychiatr Danub; 2011 Dec; 23(4):370-7. PubMed ID: 22075738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A trial of treating depressive states with cipramil].
    Iakovlev VA; Belinskiĭ AV; Dorovskikh IV
    Voen Med Zh; 2000 Jun; 321(6):53-6. PubMed ID: 10929517
    [No Abstract]   [Full Text] [Related]  

  • 34. Prevention of interferon-alpha associated depression in psychiatric risk patients with chronic hepatitis C.
    Schaefer M; Schwaiger M; Garkisch AS; Pich M; Hinzpeter A; Uebelhack R; Heinz A; van Boemmel F; Berg T
    J Hepatol; 2005 Jun; 42(6):793-8. PubMed ID: 15885349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sertraline treatment of interferon-alfa-induced depressive disorder.
    Schramm TM; Lawford BR; Macdonald GA; Cooksley WG
    Med J Aust; 2000 Oct; 173(7):359-61. PubMed ID: 11062791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of escitalopram in patients with severe depression: a pooled analysis.
    Llorca PM; Azorin JM; Despiegel N; Verpillat P
    Int J Clin Pract; 2005 Mar; 59(3):268-75. PubMed ID: 15857321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination therapy for hepatitis C.
    TreatmentUpdate; 1998 Mar; 10(1):2-3. PubMed ID: 11365430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The preclinical observation that escitalopram possesses a faster time to onset of efficacy than citalopram.
    Håkanson R
    Pharmacol Toxicol; 2002 Jan; 90(1):3-4. PubMed ID: 12005110
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment research of intermediate severity depression: what is useful for the routine patient?].
    MMW Fortschr Med; 2012 Feb; 154(2):69. PubMed ID: 22352257
    [No Abstract]   [Full Text] [Related]  

  • 40. Prescribing practices for the treatment of hepatitis C in a Veterans Affairs medical center.
    Mangin EF; Jones WN
    Am J Health Syst Pharm; 2004 Jul; 61(14):1479-82. PubMed ID: 15332696
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.